Skip to main content

Oric Pharmaceuticals, Inc.

ORIC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001796280

In the last 90 days, Oric Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; Viking Global Investors is the only superinvestor holding it.

Q2 2021 vs. Q1 2021

How the institutions holding Oric Pharmaceuticals, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of ORIC: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders8278−4
Shares35.7M36.1M+459.9K (+1.3%)
Value$874.3M$639.4M−$234.9M (−26.9%)

New holders (9)

Institutions that held Oric Pharmaceuticals, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to ORIC in Q2 2021
InstitutionSharesValue% of portfolio
Two Sigma Investments, LP30,641$542.0K0.00%
Qube Research & Technologies Ltd22,512$398.0K0.00%
Los Angeles Capital Management LLC21,900$387.0K0.00%
Citadel Advisors LLC19,315$342.0K0.00%
Invesco Ltd.11,778$209.0K0.00%
Nisa Investment Advisors, LLC3,350$59.0K0.00%
Point72 Hong Kong Ltd1,895$34.0K0.00%
O'Shaughnessy Asset Management, LLC1,544$27.0K0.00%
Simplex Trading, LLC116$2.00K0.00%

Sold out (13)

Institutions that held Oric Pharmaceuticals, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of ORIC in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
Ally Bridge Group (NY) LLC413,061$10.1M
Sphera Funds Management Ltd.169,900$4.16M
HRT Financial LP49,514$1.21M
California Public Employees Retirement System45,271$1.11M
HighVista Strategies LLC22,333$547.0K
Raymond James & Associates16,816$412.0K
Squarepoint Ops LLC10,342$253.0K
D. E. Shaw & Co., Inc.9,812$240.0K
M&T Bank Corp9,153$224.0K
C M Bidwell & Associates Ltd6,755$165.0K
SG Americas Securities, LLC5,695$140.0K
Pacer Advisors, Inc.1,572$39.0K
Bank of Montreal691$16.0K